The least developed countries (LDCs) are demanding an indefinite (read permanent) exemption from having to honor any intellectual property rights to pharmaceuticals, and the U.S. is being called “egregious” for the “meager” offer of granting a ten-year waiver from obligations. R&D Scuttled Research and development (R&D), be it pharmaceuticals or agriculture, requires a paymaster. EU farm ministers are arguing that the European Patent Office’s recent ruling granting patents to crops bred for unique traits will undermine agricultural R&D. However, the U.S. grants such protections. The result, according to the European Investment Bank, is that agricultural R&D in America is nearly 40 percent greater, and half of it is generat...